These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 12185807

  • 21. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
    Grigoriadis N, Ben-Hur T, Karussis D, Milonas I.
    Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
    Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD.
    Ann Neurol; 2000 Dec; 48(6):893-901. PubMed ID: 11117546
    [Abstract] [Full Text] [Related]

  • 24. Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders.
    De Stefano N, Narayanan S, Matthews PM, Mortilla M, Dotti MT, Federico A, Arnold DL.
    J Neurovirol; 2000 May; 6 Suppl 2():S121-9. PubMed ID: 10871799
    [Abstract] [Full Text] [Related]

  • 25. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H.
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
    Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Brück W.
    Brain; 2000 Jun; 123 ( Pt 6)():1174-83. PubMed ID: 10825356
    [Abstract] [Full Text] [Related]

  • 28. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C.
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
    Recks MS, Bader J, Kaiser CC, Schroeter M, Fink GR, Addicks K, Kuerten S.
    Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707
    [Abstract] [Full Text] [Related]

  • 31. Axonal pathology in multiple sclerosis: relationship to neurologic disability.
    Trapp BD, Ransohoff R, Rudick R.
    Curr Opin Neurol; 1999 Jun; 12(3):295-302. PubMed ID: 10499174
    [Abstract] [Full Text] [Related]

  • 32. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.
    Peterson LK, Fujinami RS.
    J Neuroimmunol; 2007 Mar; 184(1-2):37-44. PubMed ID: 17196667
    [Abstract] [Full Text] [Related]

  • 33. Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice.
    Onuki M, Ayers MM, Bernard CC, Orian JM.
    Microsc Res Tech; 2001 Mar 15; 52(6):731-9. PubMed ID: 11276125
    [Abstract] [Full Text] [Related]

  • 34. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
    Lassmann H.
    Exp Neurol; 2010 Sep 15; 225(1):2-8. PubMed ID: 19840788
    [Abstract] [Full Text] [Related]

  • 35. Novel therapeutic targets for axonal degeneration in multiple sclerosis.
    Petratos S, Azari MF, Ozturk E, Papadopoulos R, Bernard CC.
    J Neuropathol Exp Neurol; 2010 Apr 15; 69(4):323-34. PubMed ID: 20448478
    [Abstract] [Full Text] [Related]

  • 36. The relation between MRI measures of inflammation and neurodegeneration in multiple sclerosis.
    Inglese M, Benedetti B, Filippi M.
    J Neurol Sci; 2005 Jun 15; 233(1-2):15-9. PubMed ID: 15949493
    [Abstract] [Full Text] [Related]

  • 37. Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis.
    De Keyser J, Zeinstra E, Mostert J, Wilczak N.
    Trends Pharmacol Sci; 2004 Feb 15; 25(2):67-71. PubMed ID: 15102491
    [Abstract] [Full Text] [Related]

  • 38. [The evidence for primary axonal loss in multiple sclerosis].
    Anthony DC, Hughes P, Perry VH.
    Rev Neurol; 2004 Feb 15; 30(12):1203-8. PubMed ID: 10935251
    [Abstract] [Full Text] [Related]

  • 39. Remyelination protects axons from demyelination-associated axon degeneration.
    Irvine KA, Blakemore WF.
    Brain; 2008 Jun 15; 131(Pt 6):1464-77. PubMed ID: 18490361
    [Abstract] [Full Text] [Related]

  • 40. Inflammation and degeneration in multiple sclerosis.
    Brück W, Stadelmann C.
    Neurol Sci; 2003 Dec 15; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.